Cargando…
Quantitative Modeling and Simulation in PMDA: A Japanese Regulatory Perspective
In Japan in October 2016, the Pharmaceuticals and Medical Devices Agency (PMDA) began to receive electronic data in new drug applications (NDAs). These electronic data are useful to conduct regulatory assessment of sponsors’ submissions and contribute to the PMDA's research. In this article, we...
Autores principales: | Sato, M, Ochiai, Y, Kijima, S, Nagai, N, Ando, Y, Shikano, M, Nomura, Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529733/ https://www.ncbi.nlm.nih.gov/pubmed/28568566 http://dx.doi.org/10.1002/psp4.12203 |
Ejemplares similares
-
Meeting Report: PMDA Public Workshop on Pharmacometrics at Japan
por: Kijima, Shinichi, et al.
Publicado: (2020) -
Activity and perspective on quantitative modeling and simulation in Japan: Update from the Pharmaceuticals and Medical Devices Agency
por: Kijima, Shinichi, et al.
Publicado: (2022) -
Pyromellitic dianhydride (PMDA) may cause occupational asthma
por: Madsen, Milene Torp, et al.
Publicado: (2019) -
PMDA: precautions should be revised for Covid-19 vaccine
Publicado: (2021) -
Quantitative Systems Pharmacology: A Regulatory Perspective on Translation
por: Zineh, Issam
Publicado: (2019)